1,100
Participants
Start Date
December 1, 2025
Primary Completion Date
August 1, 2027
Study Completion Date
December 31, 2027
Cilostazol 100 mg
Patients allocated to the experimental arm will receive 100mg of cilostazol tablets taken twice daily. To mitigate side-effects in both treatment arms, all patients will begin one tablet daily and titrate to the full dose (one tablet twice daily) after 2 weeks. Participants will stay on the full dose of cilostazol for the remainder of the study.
Kwame Nkrumah University of Science & Technology, Kumasi
Northern California Institute of Research and Education
OTHER